Rong Zhou - 26 Aug 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
SENIOR EVP, PRODUCTION CENTER
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
26 Aug 2024
Net transactions value
-$133,600
Form type
4
Filing time
27 Aug 2024, 21:33:05 UTC
Previous filing
19 Mar 2024
Next filing
17 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Srock Options Exercise $59,800 +4,000 +3.4% $14.95 122,388 26 Aug 2024 Direct F1
transaction AMPH Common Srock Sale $193,400 -4,000 -3.3% $48.35 118,388 26 Aug 2024 Direct
holding AMPH Common Stock 99,668 26 Aug 2024 See footnote F2
holding AMPH Common Stock 5,000 26 Aug 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -4,000 -29% $0.000000 9,893 26 Aug 2024 Common Stock 4,000 $14.95 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 372 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2024.
F2 The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
F3 The shares are held of record by the reporting person's spouse.
F4 Shares subject to the option are fully vested and immediately exercisable.